Holger Reithinger

Holger Reithinger is a seasoned professional in the biotech and finance sectors, currently serving as Coordinator at BIO Deutschland e. V. since July 2024, co-heading the working group Finance & Taxes. With a robust history at Forbion since April 2010 as a Partner, Reithinger is also a Member of the Investment Committee at High-Tech Gründerfonds since September 2017. Previous board roles include Allecra Therapeutics, OMEICOS Therapeutics GmbH, CatalYm GmbH, Gotham Therapeutics, Cellnovo Group SA, and Curetis Group. Reithinger earned a PhD in Biochemistry from the MPI for Biophysics (1991-1995) and a Diplom in Biology from Ludwig-Maximilians-Universität München (1988-1991), complemented by earlier studies in Biology at Heidelberg University.